Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Effective hirsutism treatment for women with PCOS should be personalized and may include lifestyle changes and medication.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

Metformin improves acne, hair growth, and menstrual cycles in females with PCOS.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Skin cell-derived vesicles can help heal skin injuries effectively.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.